Using cinacalcet in the treatment of post-transplantation tertiary hyperparathyroidism: a report of two cases
<正>临床资料例1,男,41岁,2008年8月因慢性肾功能不全尿毒症期行血液透析治疗,每周3次。术前血清全段甲状旁腺激素(intact parathyroid hormone, iPTH)3500 ng/L。胸部CT:主动脉弓、左右冠状动脉钙化。2017年9月29日在湘雅二医院行同种异体肾移植术,术后免疫方案:他克莫司+吗替麦考酚酯+激素。2018年3月本院查血清肌酐(Scr)85 μmol/L,...
Saved in:
| Main Authors: | Xiang Hua, Zhang Hui, Chang Shuai |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2021-01-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails?columnId=57905695&Fpath=home&index=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical observation of Cinacalcet in the treatment of secondary hyperparathyroidism in hemodialysis patients
by: ZHANG Xin, et al.
Published: (2018-01-01) -
Meta-analysis of cinacalcet plus calcitriol for the treatment of secondary hyperparathyroidism in hemodialysis patients
by: Feng Hui-ling, et al.
Published: (2022-06-01) -
A Meta-analysis of Cinacalcet in the treatment of dialysis patients with secondary hyperparathyroidism
by: LV Yuan, et al.
Published: (2018-01-01) -
Preliminary exploration of the role of parathyroid volume in predicting the efficacy of cinacalcet on secondary hyperparathyroidism
by: TANG Li, et al.
Published: (2020-01-01) -
Clinical value of serum iPTH, ALP and serum markers levels in patients with secondary hyperparathyroidism receiving paricalcitol combined with cinacalcet
by: Ruifang Song, et al.
Published: (2025-01-01)